Date/Time: Monday, March 2, 2020, 6:00 – 8:15 p.m.
Location: Wiley Rein LLP, 1776 K Street, NW

Presented by the FCBA Telehealth Committee and Artificial Intelligence, Machine Learning, and Robotics Committee


6:00 ­– 6:05 p.m.         Welcome and Introductions

6:05 – 7:05 p.m.         FCC Issues and Beyond
Telehealth implicates a variety of issues at the FCC, especially with regard to funding.  In particular, what are the implications of the FCC’s 2019 decision reforming the Rural Health Care program, and what is the status of that matter at the FCC and in the courts?  What challenges do health care service providers face when participating in the program, and what impact will the FCC’s reforms have going forward?  What are the key deadlines and other issues that RHC program participants need to be thinking about?  What are the opportunities and challenges presented by the FCC’s proposed Connected Care Pilot Program?  What other telehealth-related regulatory issues (FCC and otherwise) are on the horizon?

Bob Primosch, Partner, Wilkinson Barker Knauer, LLP

Johnnay Schrieber, Attorney, Telecommunications Access Policy Division, Wireline Competition Bureau, Federal Communications Commission
Samantha Burch, Director, Health Information Technology Policy, American Hospital Association

7:05 – 7:15 p.m.         Break

7:15 – 8:15 p.m.         Artificial Intelligence in Telehealth:  Regulatory and Practical Considerations
Introducing artificial intelligence into telehealth raises a host of potential regulatory and practical issues.  For example, AI might be used for protecting the privacy of medical data, promoting cybersecurity and physical security, making hiring decisions, and running networks. What is the current roadmap for federal regulation of AI, and what sorts of regulatory guidelines are under consideration in the AI inquiry recently launched by the White House’s Office of Science and Technology Policy (OSTP)?   What sorts of strategies should service providers consider to stay ahead of the curve?  What types of liabilities could arise from use of AI in a medical setting?

Michelle Baker, Managing Director, Signal Group

Russell Hanser, Partner, Wilkinson Barker Knauer, LLP and Co-Chair, FCBA Committee on Artificial Intelligence, Machine Learning, and Robotics
Kerri Haresign, Sr. Manager, Technology & Standards, Consumer Technology Association
Catherine Pugh, Assistant Vice President – Policy, eHealth Initiative and Foundation


Register Online Download Registration Form